全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 744961-76-0 | N-(4-Methylphenyl)-2-(propylamino)propanamide | C13H20N2O |
| 744985-64-6 | (5-Bromo-3-benzo[b]thienyl)methylamine | C9H8BrNS |
| 745017-94-1 | Monomethylauristatin F;MMAF | C39H65N5O8 |
| 745038-86-2 | Lithium dichloro(1-methylethyl)-magnesate(1-);745038-86-2 | C3H7Cl2Mg.Li |
| 745046-84-8 | Caspase-3 Inhibitor VII;2-[2-(Acetyloxy)ethyl]-4-methyl-8-(4-morpholinylsulfonyl)-1H-pyrrolo[3,4-c]quinoline-1,3(2H)-dione; Ivachtin | C20H21N3O7S |
| 745047-53-4 | N1-(2,4-Dimethoxybenzyl)-N2-(2-(pyridin-2-yl)ethyl)oxalamide;N'-[(2,4-dimethoxyphenyl)methyl]-N-(2-pyridin-2-ylethyl)oxamide | C18H21N3O4 |
| 745047-94-3 | N-[(2-Methoxy-4-methylphenyl)methyl]-N'-[2-(5-methyl-2-pyridinyl)ethyl]ethanediamide | C19H23N3O3 |
| 745048-63-9 | 5-Amino-2-bromo-4-methylbenzoic acid;3-Amino-6-bromo-4-methylbenzoic acid | C8H8BrNO2 |
| 745052-92-0 | Triphenyl(tetrahydropyran-4-ylmethyl)phosphonium iodide;Triphenyl[(tetrahydro-2H-pyran-4-yl)methyl]phosphonium iodide | C24H26OP.I |
| 745052-94-2 | Ethyl 2-[4-(cyclopropylsulfanyl)phenyl]-2-oxoacetate;Ethyl 2-[4-(cyclopropylthio)phenyl]-2-oxoacetate; Ethyl [4-(cyclopropylsulfanyl)phenyl]oxoacetate; [4-(Cyclopropylsulfanyl)phenyl](oxo)acetic acid ethyl ester; [4-(Cyclopropylthio)phenyl](oxo)acetic acid ethyl ester | C13H14O3S |
| 745053-64-9 | 5-Fluorothiazol-2-amine hydrochloride | C3H3FN2S.HCl |
| 745055-24-7 | 3-[3-[4-(2-Methoxyethoxy)phenyl]-1,2,4-oxadiazol-5-yl]benzoic acid | C18H16N2O5 |
| 745078-74-4 | 5-(3-Bromophenyl)isoxazole-3-carboxylic acid methyl ester | C11H8BrNO3 |
| 745784-04-7 | 3,5-Difluoropyridine-2-carboxylic acid;3,5-Difluoropicolinic acid | C6H3F2NO2 |
| 745784-12-7 | 2-Quinolinylboronic acid;Quinoline-2-boronic acid | C9H8BNO2 |
| 745798-07-6 | 2,2'-Iminobis(N-(2,6-dimethylphenyl)acetamide;2-[[2-(2,6-dimethylanilino)-2-oxoethyl]amino]-N-(2,6-dimethylphenyl)acetamide | C20H25N3O2 |
| 745833-19-6 | Ethyl 2-(2,4-difluorophenyl)-6-chloronicotinate;6-Chloro-2-(2,4-difluoro-phenyl)nicotinic acid ethyl ester | C14H10ClF2NO2 |
| 745833-23-2 | VX 702;6-[(Aminocarbonyl)(2,6-difluorophenyl)amino]-2-(2,4-difluorophenyl)-3-pyridinecarboxamide | C19H12F4N4O2 |
| 745836-29-7 | (1R,4R,7R)-rel-2-(Phenylmethyl)-2-azabicyclo[2.2.1]heptan-7-ol;anti-7-Hydroxy-2-benzyl-2-azabicyclo[2.2.1]heptane | C13H17NO |
| 746598-16-3 | 3-Amino-3-cyclobutylmethyl-2-hydroxypropionamide | C8H16N2O2 |
| 746630-34-2 | 1-(4-Bromo-2,6-difluorophenyl)ethanone | C8H5BrF2O |
| 746651-52-5 | 3,6-Dibromo-9-(4-methoxyphenyl)-9H-carbazole | C19H13Br2NO |
| 746656-39-3 | 4-(3-Hydroxyphenyl)-4H-1,2,4-triazole | C8H7N3O |
| 746657-36-3 | (1R,2S)-1-Amino-2-ethenylcyclopropanecarboxylic acid ethyl ester | C8H13NO2 |
| 746668-73-5 | 4-Bromo-1-methoxyisoquinoline | C10H8BrNO |
| 747353-15-7 | 3-Methyl-3H-spiro[2-benzofuran-1,4'-piperidine];3-Methylspiro[isobenzofuran-1(3H),4'-piperidine] | C13H17NO |
| 747392-34-3 | 2-Bromo-5-fluorobenzylamine | C7H7BrFN |
| 747412-49-3 | AUY 922;5-[2,4-Dihydroxy-5-isopropylphenyl]-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-3-isoxazolecarboxamide | C26H31N3O5 |
| 747413-08-7 | 5-(5-Chloro-2,4-dihydroxyphenyl)-N-ethyl-4-(4-methoxyphenyl)-3-isoxazolecarboxamide;VER 50589 | C19H17ClN2O5 |
| 747413-21-4 | 4-(4-Methyl-1-piperazinyl)benzeneboronic acid pinacol ester;1-Methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine | C17H27BN2O2 |
| 747414-17-1 | 1-(2,4-Dihydroxy-5-isopropylphenyl)ethanone | C11H14O3 |
| 747414-20-6 | Ethyl 5-[2,4-bis(benzyloxy)-5-isopropylphenyl]isoxazole-3-carboxylate | C29H29NO5 |
| 747414-24-0 | N-Ethyl-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phenyl]-4-[4-(4-morpholinylmethyl)phenyl]-3-isoxazolecarboxamide | C40H43N3O5 |
| 748117-01-3 | (3S)-3-Ethylmorpholine | C6H13NO |
| 748124-46-1 | 3,4-Difluoro-N-methylbenzenemethanamine;(3,4-Difluorophenyl)methyl](methyl)amine | C8H9F2N |
| 748746-28-3 | Methyl 3-amino-4,4,4-trifluorobutanoate | C5H8F3NO2 |
| 748766-92-9 | (R)-2-(Methyl(pyrrolidin-3-yl)amino)ethanol | C7H16N2O |
| 748777-12-0 | (2S,3R)-Methyl 2-(4-methoxyphenyl)pyrrolidine-3-carboxylate | C13H17NO3 |
| 748796-38-5 | (6-(1H-Pyrazol-1-yl)pyridin-3-yl)methanol | C9H9N3O |
| 748796-39-6 | 5-Chloromethyl-2-(pyrazol-1-yl)pyridine | C9H8ClN3 |
| 748797-09-3 | 3-Pyrrolidinepropanoic acid ethyl ester;3-(3-Pyrrolidinyl)propanoic acid ethyl ester | C9H17NO2 |
| 748799-31-7 | (4S)-7-Chloro-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione | C13H12ClNO5 |
| 748805-97-2 | 6-Oxo-[1,4]oxazepane-4-carboxylic acid tert-butyl ester;tert-Butyl 6-oxo-1,4-oxazepan-4-carboxylate; tert-Butyl 6-oxo-1,4-oxazepane-4-carboxylate | C10H17NO4 |
| 748810-28-8 | Vernakalant hydrochloride;RSD 1235; (3R)-1-[(1R,2R)-2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol monohydrochloride | C20H31NO4.HCl |
| 748812-37-5 | 2-Amino-5-bromo-3-fluoropyridine | C5H4BrFN2 |
| 748812-53-5 | Irbesartan Related Compound A;1-[(1-Oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]cyclopentanecarboxamide | C25H30N6O2 |
| 749223-61-8 | 6-Methoxy-1H-indazol-5-amine | C8H9N3O |
| 749230-32-8 | 2,6-Difluoro-3-hydroxybenzoic acid | C7H4F2O3 |
| 749230-45-3 | 3,4-Difluoro-5-hydroxybenzoic acid | C7H4F2O3 |
| 749230-47-5 | 2,3-Difluoro-6-hydroxybenzoic acid | C7H4F2O3 |